Joanne Marie Torres, MD | |
2520 Cherry Ave, Bremerton, WA 98310-4229 | |
(360) 377-3911 | |
Not Available |
Full Name | Joanne Marie Torres |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Experience | 23 Years |
Location | 2520 Cherry Ave, Bremerton, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316977317 | NPI | - | NPPES |
0103810872 | Other | MI | BCBSM/WA FOOTE MEMORIAL |
4785739 | Medicaid | MI | |
104770772 | Medicaid | MI | |
8486516 | Medicaid | WA | |
P00247222 | Other | MI | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 4301078537 (Michigan) | Secondary |
207P00000X | Emergency Medicine | MD00048174 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
iBio, Inc. announced today that it has agreed in principle to license its technology, the iBioLaunch™ platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas. The "GreenVax Project" will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment.
As Democrats struggle with the health reform proposal from Sen. Max Baucus, the GOP is hoping to seize the advantage.
Seguro Surgical, Inc., a medical device development company specializing in the commercialization of surgical instrumentation, today announced that it has acquired, from The Johns Hopkins University, the global marketing rights to a novel device for use in abdominal surgery.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Kenneth Longmuir, associate professor of physiology & biophysics, and Richard Robertson, professor of anatomy & neurobiology, used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally-occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent doxorubicin, and a small peptide molecule to "address" the package to the targeted tissue.
› Verified 6 days ago
Entity Name | Kaiser Foundation Health Plan Of Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
iBio, Inc. announced today that it has agreed in principle to license its technology, the iBioLaunch™ platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas. The "GreenVax Project" will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment.
As Democrats struggle with the health reform proposal from Sen. Max Baucus, the GOP is hoping to seize the advantage.
Seguro Surgical, Inc., a medical device development company specializing in the commercialization of surgical instrumentation, today announced that it has acquired, from The Johns Hopkins University, the global marketing rights to a novel device for use in abdominal surgery.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Kenneth Longmuir, associate professor of physiology & biophysics, and Richard Robertson, professor of anatomy & neurobiology, used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally-occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent doxorubicin, and a small peptide molecule to "address" the package to the targeted tissue.
› Verified 6 days ago
Entity Name | West Sound Emergency Physicians Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568489243 PECOS PAC ID: 9234133703 Enrollment ID: O20060914000454 |
News Archive
iBio, Inc. announced today that it has agreed in principle to license its technology, the iBioLaunch™ platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas. The "GreenVax Project" will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment.
As Democrats struggle with the health reform proposal from Sen. Max Baucus, the GOP is hoping to seize the advantage.
Seguro Surgical, Inc., a medical device development company specializing in the commercialization of surgical instrumentation, today announced that it has acquired, from The Johns Hopkins University, the global marketing rights to a novel device for use in abdominal surgery.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Kenneth Longmuir, associate professor of physiology & biophysics, and Richard Robertson, professor of anatomy & neurobiology, used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally-occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent doxorubicin, and a small peptide molecule to "address" the package to the targeted tissue.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Joanne Marie Torres, MD 7424 108th St Nw, Gig Harbor, WA 98332-6864 Ph: (734) 975-1891 | Joanne Marie Torres, MD 2520 Cherry Ave, Bremerton, WA 98310-4229 Ph: (360) 377-3911 |
News Archive
iBio, Inc. announced today that it has agreed in principle to license its technology, the iBioLaunch™ platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas. The "GreenVax Project" will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment.
As Democrats struggle with the health reform proposal from Sen. Max Baucus, the GOP is hoping to seize the advantage.
Seguro Surgical, Inc., a medical device development company specializing in the commercialization of surgical instrumentation, today announced that it has acquired, from The Johns Hopkins University, the global marketing rights to a novel device for use in abdominal surgery.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Kenneth Longmuir, associate professor of physiology & biophysics, and Richard Robertson, professor of anatomy & neurobiology, used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally-occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent doxorubicin, and a small peptide molecule to "address" the package to the targeted tissue.
› Verified 6 days ago
Glen Carlson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 Cherry Ave, Bremerton, WA 98310 Phone: 360-377-3911 | |
Dr. William Byrne Cogar, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4000 | |
William M Roberts, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4426 Fax: 360-475-4344 | |
Bernard Greenfeld, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1651 Ne Bentley Dr, Bremerton, WA 98311 Phone: 360-782-3400 Fax: 360-782-3440 | |
Martin A. Bennett, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 Cherry Ave, Bremerton, WA 98310 Phone: 360-377-3911 | |
Dr. Randy L Baldwin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4426 Fax: 360-475-4344 | |
Dr. Paul Arthur Dutky, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3914 Nw Fairway Ln, Bremerton, WA 98312 Phone: 360-479-2683 Fax: 360-479-2683 |